Volker Knappertz Aurinia Pharmaceuticals Inc. (AUPH) insider trading activity

AUPH Quotes by TradingView

Volker Knappertz is EVP, Research and Development of Aurinia Pharmaceuticals Inc.. Currently has a direct ownership of 319,128 shares of AUPH, which is worth approximately $2.95 Million. The most recent transaction as insider was on Feb 27, 2024, when has been sold 4,930 shares (Common Stock) at a price of $6.1 per share, resulting in proceeds of $30,073. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 319K
0% 3M change
7.3% 12M change
Total Value Held $2.95 Million

Volker Knappertz Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 27 2024
SELL
Open market or private sale
$30,073 $6.1 p/Share
4,930 Reduced 1.52%
319,128 Common Stock
Feb 20 2024
SELL
Open market or private sale
$137,800 $5.48 p/Share
25,146 Reduced 7.2%
324,058 Common Stock
Mar 02 2023
BUY
Grant, award, or other acquisition
-
191,462 Added 35.74%
344,274 Common Stock
VK

Volker Knappertz

EVP, Research and Development
Victoria, A1

Track Institutional and Insider Activities on AUPH

Follow Aurinia Pharmaceuticals Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUPH shares.

Notify only if

Insider Trading

Get notified when an Aurinia Pharmaceuticals Inc. insider buys or sells AUPH shares.

Notify only if

News

Receive news related to Aurinia Pharmaceuticals Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AUPH